Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Shares Issued (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Shares Issued for 4 consecutive years, with $5000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued rose 109.62% to $5000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $5000.0, a N/A change, with the full-year FY2025 number at $5000.0, changed N/A from a year prior.
  • Shares Issued was $5000.0 for Q4 2025 at Spruce Biosciences, up from -$52000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $53.6 million in Q4 2023 to a low of -$128000.0 in Q3 2024.
  • A 4-year average of $5.4 million and a median of $3500.0 in 2022 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: soared 141173.68% in 2023, then crashed 100.1% in 2024.
  • Spruce Biosciences' Shares Issued stood at -$38000.0 in 2022, then skyrocketed by 141173.68% to $53.6 million in 2023, then plummeted by 100.1% to -$52000.0 in 2024, then soared by 109.62% to $5000.0 in 2025.
  • Per Business Quant, the three most recent readings for SPRB's Shares Issued are $5000.0 (Q4 2025), -$52000.0 (Q4 2024), and -$128000.0 (Q3 2024).